| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NeuBase Therapeutics, Inc. | Director | Stock option (right to buy) | 37,600 | 09 Sep 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NBSE | NeuBase Therapeutics, Inc. | 09 Sep 2022 | 1 | $0 | 4 | Director | 12 Sep 2022, 17:01 |
| NBSE | NeuBase Therapeutics, Inc. | 19 Aug 2021 | 1 | $0 | 4 | Director | 17 Sep 2021, 16:17 |
| NBSE | NeuBase Therapeutics, Inc. | 11 May 2021 | 1 | $0 | 4 | Director | 13 May 2021, 18:03 |
| NBSE | NeuBase Therapeutics, Inc. | 11 May 2021 | 0 | $0 | 3 | Director | 13 May 2021, 18:02 |